Name: UMIN ID:
Unique ID issued by UMIN | UMIN000037747 |
---|---|
Receipt number | R000043048 |
Scientific Title | The Real-World Clinical Benefits of Following Therapy after Trastuzumab Emtansine (T-DM1) for HER2-positive Metastatic Breast Cancer: A Multicentral Cohort Study(WJOG12519B) |
Date of disclosure of the study information | 2019/08/26 |
Last modified on | 2021/02/18 13:11:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/08/20 17:21:15 | ||
2 | Update | 2019/08/26 09:15:39 | Recruitment status Date of IRB |
|
3 | Update | 2019/11/28 17:13:01 | Recruitment status |
|
4 | Update | 2021/02/18 13:11:16 | Recruitment status |